Tag - medicine-4

 
 

MEDICINE 4

Japan Times
ASIA PACIFIC / Science & Health
Feb 19, 2022
These vaccines have been embraced by the world. Why not in China?
Two years into the pandemic, China's 1.4 billion people still don't have access to one of the most effective coronavirus vaccines the world has to offer.
Japan Times
COMMENTARY / Japan
Feb 18, 2022
Investments in health systems will protect human security now, and into the future
COVID-19 has exposed the deep inequities and weaknesses in the global health system.
Japan Times
WORLD
Feb 14, 2022
Here’s what the pandemic has in store for the world next
As a virus-weary world limps through the third year of the outbreak, experts warn that omicron won't be the last variant we have to contend with.
Japan Times
COMMENTARY / World
Feb 11, 2022
Breaking the coronavirus pandemic's grip
There is a significant risk that we will become trapped in an endless cycle of booster vaccinations, chasing the virus rather than getting ahead of it.
Japan Times
JAPAN / Science & Health
Feb 10, 2022
Japanese health ministry approves Pfizer's COVID-19 oral treatment drug
The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of developing severe symptoms.
Japan Times
WORLD
Feb 4, 2022
COVID’s endemic shift means a slowdown for virus product makers
Demand for at-home tests will probably slow first while sales of more reliable PCRs will show more resilience, according to medical supply executives.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
Japan Times
WORLD / Science & Health
Jan 24, 2022
Rich countries lure health workers from low-income nations to fight shortages
The urgency and strong pull from high-income nations has raised new questions about the ethics of recruitment from countries with weak health systems during a pandemic.
Japan Times
ASIA PACIFIC / Science & Health
Jan 16, 2022
Beijing tightens rules for entering city after omicron case
On Saturday, the Beijing reported the first local infection of the omicron variant involving a person who had visited multiple malls and restaurants in the previous days.
Japan Times
WORLD / Science & Health
Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Japan Times
COMMENTARY / World
Jan 14, 2022
The great COVID-19 coverup
COVID-19 deaths make all the headlines, but what flies under the radar are the increased rates of obesity, unemployment, depression, alcoholism and suicides.
Japan Times
COMMENTARY / Japan
Jan 12, 2022
SOFA exempts U.S. forces from Japan’s laws, as it does its COVID safety measures
Beyond the issues associated with the U.S. military's lax COVID-19 containment measures, SOFA has a long history of incidents.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Pfizer starts making vaccine that targets both omicron and the original COVID virus
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
Japan Times
COMMENTARY / World
Jan 10, 2022
Unvaccinated creating another kind of COVID-19 victim
People who make choices that are likely to harm others, such as refusing vaccinations, and have been warned of the consequences of those choices must take responsibility for them.
Japan Times
ASIA PACIFIC / Politics
Jan 6, 2022
Hair-loss treatment for votes? South Korea's hairy debate
The Democratic Party presidential candidate has divided opinion with his proposal to allow public health care insurance to cover hair-loss treatment.
Japan Times
COMMENTARY / World
Jan 5, 2022
Boris Johnson and the woeful and costly Tory war on woke
While freedom-loving Tories make their last stand, the evidence shows that coordinated action by governments and solidarity among citizens are what will contain the pandemic.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?